1.Role of VEGF in Kidney Development, Microvascular Maintenance and Pathophysiology of Renal Disease.
Byung Soo KIM ; Michael S GOLIGORSKY
The Korean Journal of Internal Medicine 2003;18(2):65-75
Vascular endothelial growth factor, VEGF, is essential for endothelial cell differentiation (vasculogenesis) and for the sprouting of new capillaries from preexisting vessels (angiogenesis). In addition, there is strong evidence that VEGF is a survival factor allowing the cells to survive and proliferate under conditions of extreme stress. Hypoxia is a key regulator of VEGF gene expression. Besides hypoxia, many cytokines, hormones and growth factors can up-regulate VEGF mRNA expression in various cell types. VEGF is present in the glomerulus of both the fetal and adult kidney. The VEGF produced by glomerular epithelial cell may be responsible for maintenance of the fenestrated phenotype of glomerular epithelial cells, thus facilitating the high rate of glomerular ultrafiltration. But there is little known about the role of VEGF in the tubule. VEGF is thought to be involved in many kinds of kidney diseases. Whereas VEGF has a beneficial role in the pathogenesis in some diseases, it does harmful action in others. Because VEGF is known to be associated with the pathogenesis of some diseases, such as diabetic nephropathy, renal tumor and polycystic kidney disease, the study about the role of VEGF is going to be a target for disease control. On the other hand, an attempt at enhancing the role of VEGF has to be made at diseases like several ARF models and experimental glomerulonephritis.
Animals
;
Endothelial Growth Factors/genetics/*metabolism
;
Gene Expression
;
Human
;
Intercellular Signaling Peptides and Proteins/genetics/*metabolism
;
Kidney Diseases/*metabolism/physiopathology
;
Kidney Glomerulus/*metabolism
;
Kidney Tubules/*metabolism
;
Lymphokines/genetics/*metabolism
;
Protein Isoforms/genetics/metabolism
;
Receptors, Vascular Endothelial Growth Factor/metabolism
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factors
2.Pathogenesis of endothelial cell dysfunction in chronic kidney disease: a retrospective and what the future may hold.
Kidney Research and Clinical Practice 2015;34(2):76-82
Cardiovascular complications dominate the landscape of chronic kidney diseases (CKD). Endothelial cell dysfunction (ECD) is a well-known culprit of cardiovascular morbidity and it develops in CKD with remarkable frequency. This brief overview of ECD in CKD scans two decades of studies performed in my laboratory, from genetic analyses to proteomic and metabolomics screens. I provide a detailed description of findings related to the premature senescence of endothelial cells, cell transition from the endothelial to mesenchymal phenotype, and stages of development of ECD. Clinical utility of some of these findings is illustrated with data on laser-Doppler flowmetry and imaging in patients with CKD. Some currently available and emerging therapeutic options for the management of ECD are briefly presented.
Aging
;
Endothelial Cells*
;
Humans
;
Laser-Doppler Flowmetry
;
Metabolomics
;
Phenotype
;
Renal Insufficiency, Chronic*
;
Retrospective Studies*
3.Perioperative implication of the endothelial glycocalyx.
Jong Wook SONG ; Michael S GOLIGORSKY
Korean Journal of Anesthesiology 2018;71(2):92-102
The endothelial glycocalyx (EG) is a gel-like layer lining the luminal surface of healthy vascular endothelium. Recently, the EG has gained extensive interest as a crucial regulator of endothelial funtction, including vascular permeability, mechanotransduction, and the interaction between endothelial and circulating blood cells. The EG is degraded by various enzymes and reactive oxygen species upon pro-inflammatory stimulus. Ischemia-reperfusion injury, oxidative stress, hypervolemia, and systemic inflammatory response are responsible for perioperative EG degradation. Perioperative damage of the EG has also been demonstrated, especially in cardiac surgery. However, the protection of the EG and its association with perioperative morbidity needs to be elucidated in future studies. In this review, the present knowledge about EG and its perioperative implication is discussed from an anesthesiologist's perspective.
Blood Cells
;
Capillary Permeability
;
Endothelium, Vascular
;
Glycocalyx*
;
Oxidative Stress
;
Permeability
;
Phenobarbital
;
Reactive Oxygen Species
;
Reperfusion Injury
;
Thoracic Surgery